Marker Therapeutics OverviewMarker Therapeutics Net Income
Profitability analysis for MRKR.
Quarterly Net Income
-$3.18M
↑ 28.49% YoY
As of Mar 2026
Annual Net Income (TTM)
-$12163.62B
↓ 95142066.94% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...